Literature DB >> 15764027

Delivery and tracking of therapeutic cell preparations for clinical cardiovascular applications.

R de Silva1, R J Lederman.   

Abstract

Experimental observations suggesting adult stem cell plasticity and cross-lineage transdifferentiation have underpinned the investigation of cell therapy for cardiovascular disease. Many challenges still face the full realization of cardiovascular regenerative medicine. This brief review will highlight some of these, with emphasis on the choice of cell preparation, route of cell delivery and tracking of delivered cells.

Entities:  

Mesh:

Year:  2004        PMID: 15764027      PMCID: PMC1325105          DOI: 10.1080/14653240410005339

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  35 in total

1.  Incomplete retention after direct myocardial injection.

Authors:  P Michael Grossman; Zhenguo Han; Maria Palasis; James J Barry; Robert J Lederman
Journal:  Catheter Cardiovasc Interv       Date:  2002-03       Impact factor: 2.692

2.  Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy.

Authors:  Albert A Hagège; Claire Carrion; Philippe Menasché; Jean-Thomas Vilquin; Denis Duboc; Jean-Pierre Marolleau; Michel Desnos; Patrick Bruneval
Journal:  Lancet       Date:  2003-02-08       Impact factor: 79.321

3.  Pluripotency of mesenchymal stem cells derived from adult marrow.

Authors:  Yuehua Jiang; Balkrishna N Jahagirdar; R Lee Reinhardt; Robert E Schwartz; C Dirk Keene; Xilma R Ortiz-Gonzalez; Morayma Reyes; Todd Lenvik; Troy Lund; Mark Blackstad; Jingbo Du; Sara Aldrich; Aaron Lisberg; Walter C Low; David A Largaespada; Catherine M Verfaillie
Journal:  Nature       Date:  2002-06-20       Impact factor: 49.962

4.  Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).

Authors:  Birgit Assmus; Volker Schächinger; Claudius Teupe; Martina Britten; Ralf Lehmann; Natascha Döbert; Frank Grünwald; Alexandra Aicher; Carmen Urbich; Hans Martin; Dieter Hoelzer; Stefanie Dimmeler; Andreas M Zeiher
Journal:  Circulation       Date:  2002-12-10       Impact factor: 29.690

5.  Therapeutic angiogenesis induced by local autologous bone marrow cell implantation.

Authors:  Kimikazu Hamano; Tao-Sheng Li; Toshiro Kobayashi; Ken Hirata; Masafumi Yano; Michihiro Kohno; Masunori Matsuzaki
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

6.  Time course and determinants of left ventricular function recovery after primary angioplasty in patients with acute myocardial infarction.

Authors:  I Sheiban; G Fragasso; G M Rosano; A Dharmadhikari; V Tzifos; P Pagnotta; S L Chierchia; G Trevi
Journal:  J Am Coll Cardiol       Date:  2001-08       Impact factor: 24.094

7.  Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans.

Authors:  Bodo E Strauer; Michael Brehm; Tobias Zeus; Matthias Köstering; Anna Hernandez; Rüdiger V Sorg; Gesine Kögler; Peter Wernet
Journal:  Circulation       Date:  2002-10-08       Impact factor: 29.690

8.  Mobilized bone marrow cells repair the infarcted heart, improving function and survival.

Authors:  D Orlic; J Kajstura; S Chimenti; F Limana; I Jakoniuk; F Quaini; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

9.  Autologous bone-marrow stem-cell transplantation for myocardial regeneration.

Authors:  Christof Stamm; Bernd Westphal; Hans-Dieter Kleine; Michael Petzsch; Christian Kittner; Heiko Klinge; Carl Schümichen; Christoph A Nienaber; Mathias Freund; Gustav Steinhoff
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation.

Authors:  Hung-Fat Tse; Yok-Lam Kwong; John K F Chan; Gladys Lo; Chi-Lai Ho; Chu-Pak Lau
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.